Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas

作者: Rolf F. Barth

DOI: 10.1023/A:1005805203044

关键词:

摘要: Rat brain tumor models have been widely used in experimental neuro-oncology for almost three decades. The present review, which will be selective rather than comprehensive, focus entirely on seven rat and their utility evaluating the efficacy of various therapeutic modalities. Although no currently available animal model exactly simulates human high grade tumors, that are provided a wealth information vitro vivo biochemical biological properties tumors responses to Ideally, valid should derived from glial cells, grow with predictable reproducible growth patterns simulate gliomas, weakly or non-immunogenic, response therapy, lack thereof, resemble tumors. following discussed. 9L gliosarcoma, was chemically induced an inbred Fischer rat, has one most all much useful relating biology therapy. T9 glioma, although generally unrecognized, probably still is same as 9L. Both these can immunogenic under appropriate circumstances, this must taken into consideration when using either them studies efficacy, especially if survival endpoint. C6 outbred Wistar extensively variety studies, but not syngeneic any strain. Its potential evoke alloimmune serious limitation, it being studies. F98 RG2 (D74) gliomas were both appear non-immunogenic. These refractory modalities invasive pattern uniform lethality innoculum few 10 cells make particularly attractive test new Avian Sarcoma Virus continuous cell line them, designated RT-2, de novo induction important requirement. however, may limit usefulness Finally, recently described, CNS-1, appears number neuro-oncology. It essential recognize, limitations each depending upon nature study conducted, selected.

参考文章(144)
George Morstyn, Andrew H. Kaye, Ian Gardner, Ken Pyke, Development of a xenograft glioma model in mouse brain. Cancer Research. ,vol. 46, pp. 1367- 1373 ,(1986)
Zvi Ram, Stuart Walbridge, John D. Heiss, Kenneth W. Culver, R. Michael Blaese, Edward H. Oldfield, In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors Journal of Neurosurgery. ,vol. 80, pp. 535- 540 ,(1994) , 10.3171/JNS.1994.80.3.0535
Charles G. Orosz, Steven M. James, Rolf F. Barth, Jone-Jiun Tzeng, Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Cancer Research. ,vol. 51, pp. 2373- 2378 ,(1991)
Ronald G. Blasberg, Darell D. Bigner, Nicholas A. Vick, Joan M. Fischer, Joseph F. Pasternak, Dennis R. Groothuis, Regional Measurements of Blood-to-Tissue Transport in Experimental RG-2 Rat Gliomas Cancer Research. ,vol. 43, pp. 3368- 3373 ,(1983)
William R. Shapiro, David P. Rall, James I. Ausman, Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Research. ,vol. 30, pp. 2394- 2400 ,(1970)
Stanley I. Rapoport, Osmotic opening of the blood-brain barrier. Ciba Foundation Symposium 56 - Cerebral Vascular Smooth Muscle and Its Control. pp. 237- 255 ,(1978) , 10.1002/9780470720370.CH13
Mariana Resnicoff, Michele Rubini, Raphael Rubin, Christian Sell, Renato Baserga, Domenico Coppola, Diane Ambrose, Rat Glioblastoma Cells Expressing an Antisense RNA to the Insulin-like Growth Factor-1 (IGF-1) Receptor Are Nontumorigenic and Induce Regression of Wild-Type Tumors Cancer Research. ,vol. 54, pp. 2218- 2222 ,(1994)
Nancy R. Clendenon, Wanda A. Gordon, Rolf F. Barth, Jone-Jiun Tzeng, Adoptive Immunotherapy of a Rat Glioma Using Lymphokine-activated Killer Cells and Interleukin 2 Cancer Research. ,vol. 50, pp. 4338- 4343 ,(1990)
I Mottet, Jean Pierre Brion, Roger Demeure, Jean Noël Octave, A Maron, A Le Roux, J F Dedieu, M Perricaudet, T Gustin, Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Therapy. ,vol. 3, pp. 315- 322 ,(1996)